Luteal Faz Yetmezliği

Özet

Referanslar

Practice Committees of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility Diagnosis and treatment of luteal phase deficiency: a committee opinion.Fertil Steril. 2021 Jun;115(6):1416-1423

Muneeba Jr. S, Acharya N,and Mohammad S. The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review. Cureus. 2023 Nov; 15(11): e48194.Published online 2023 Nov 3.

Saxtorph M.H, Hallager T, Persson G,et all.Assessing endometrial receptivity after recurrent implantation failure: a prospective controlled cohort study .Reprod Biomed Online2020 Dec;41(6):998-1006.

Ranisavljevic N, Huberlant S, Montagut M,et all.Low Luteal Serum Progesterone Levels Are Associated With Lower Ongoing Pregnancy and Live Birth Rates in ART: Systematic Review and Meta-Analyses .Front Endocrinol (Lausanne). 2022 Jun 10:13:892753.

Coomarasamy A , Devall A.J. , Brosens J.J. ,et all.Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence .Am J Obstet Gynecol2020 Aug;223(2):167-176.

Dal J,Vural B ,Caliskan E,et all. Power Doppler ultrasound studies of ovarian, uterine, and endometrial blood flow in regularly menstruating women with respect to luteal phase defects Fertil Steril 2005 Jul;84(1):224-7.

Palomba S, Santagni S, Battista La Sala G, Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? Cureus. 2023 Nov; 15(11): e48194.

Muneeba S, Jr., Acharya N,Mohammad S The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review Helion Volume 10, Issue 15, 15 August 2024, e35088

Nillius SJ, Johansson ED. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol. 1971;110:470–477

Orazov MR, Radzinskiy VE, Nosenko EN et all, Combination therapeutic options in the treatment of the luteal phase deficiency Gynecol Endocrinol. 2017;33(sup1):1-4.

Mendoza-Tesarik R, Mendoza N, López CC et all. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study.Reprod Biomed Online. 2019 Aug;39(2):225-230

Gün İ, Özdamar Ö, Yılmaz A. Luteal phase support in intrauterine insemination cycles.Turk J Obstet Gynecol. 2016 Jun;13(2):90-94.

de Ziegler D, Pirtea P, Andersen CY, Ayoubi JM. Role of gonadotropin-releasing hormone agonists, human chorionic gonadotropin (hCG), progesterone, and estrogen in luteal phase support after hCG triggering, and when in pregnancy hormonal support can be stopped. Fertil Steril. 2018;109:749–755

Ghazeeri G.S, Nassar A.H, Younes Z et all. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.J Ovarian Res. 2015; 8: 77.

Lawrenz B, Coughlan C, Fatemi HM. Individualized luteal phase support. Curr Opin Obstet Gynecol. 2019;31:177–182.

Nigam A. Luteal phase support: Why, when and how. Pan Asian J Obs Gyn. 2018;1:79–83.

Suthaporn S, Jayaprakasan K, Maalouf W, Thornton JG, Walker KF. The strength of evidence supporting luteal phase progestogen after assisted reproduction: A systematic review with reference to trial registration and pre-specified endpoints. Eur J Obstet Gynecol Reprod Biol. 2020;245:149–161

Referanslar

Practice Committees of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility Diagnosis and treatment of luteal phase deficiency: a committee opinion.Fertil Steril. 2021 Jun;115(6):1416-1423

Muneeba Jr. S, Acharya N,and Mohammad S. The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review. Cureus. 2023 Nov; 15(11): e48194.Published online 2023 Nov 3.

Saxtorph M.H, Hallager T, Persson G,et all.Assessing endometrial receptivity after recurrent implantation failure: a prospective controlled cohort study .Reprod Biomed Online2020 Dec;41(6):998-1006.

Ranisavljevic N, Huberlant S, Montagut M,et all.Low Luteal Serum Progesterone Levels Are Associated With Lower Ongoing Pregnancy and Live Birth Rates in ART: Systematic Review and Meta-Analyses .Front Endocrinol (Lausanne). 2022 Jun 10:13:892753.

Coomarasamy A , Devall A.J. , Brosens J.J. ,et all.Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence .Am J Obstet Gynecol2020 Aug;223(2):167-176.

Dal J,Vural B ,Caliskan E,et all. Power Doppler ultrasound studies of ovarian, uterine, and endometrial blood flow in regularly menstruating women with respect to luteal phase defects Fertil Steril 2005 Jul;84(1):224-7.

Palomba S, Santagni S, Battista La Sala G, Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? Cureus. 2023 Nov; 15(11): e48194.

Muneeba S, Jr., Acharya N,Mohammad S The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review Helion Volume 10, Issue 15, 15 August 2024, e35088

Nillius SJ, Johansson ED. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol. 1971;110:470–477

Orazov MR, Radzinskiy VE, Nosenko EN et all, Combination therapeutic options in the treatment of the luteal phase deficiency Gynecol Endocrinol. 2017;33(sup1):1-4.

Mendoza-Tesarik R, Mendoza N, López CC et all. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study.Reprod Biomed Online. 2019 Aug;39(2):225-230

Gün İ, Özdamar Ö, Yılmaz A. Luteal phase support in intrauterine insemination cycles.Turk J Obstet Gynecol. 2016 Jun;13(2):90-94.

de Ziegler D, Pirtea P, Andersen CY, Ayoubi JM. Role of gonadotropin-releasing hormone agonists, human chorionic gonadotropin (hCG), progesterone, and estrogen in luteal phase support after hCG triggering, and when in pregnancy hormonal support can be stopped. Fertil Steril. 2018;109:749–755

Ghazeeri G.S, Nassar A.H, Younes Z et all. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.J Ovarian Res. 2015; 8: 77.

Lawrenz B, Coughlan C, Fatemi HM. Individualized luteal phase support. Curr Opin Obstet Gynecol. 2019;31:177–182.

Nigam A. Luteal phase support: Why, when and how. Pan Asian J Obs Gyn. 2018;1:79–83.

Suthaporn S, Jayaprakasan K, Maalouf W, Thornton JG, Walker KF. The strength of evidence supporting luteal phase progestogen after assisted reproduction: A systematic review with reference to trial registration and pre-specified endpoints. Eur J Obstet Gynecol Reprod Biol. 2020;245:149–161

Yayınlanan

8 Kasım 2024

Lisans

Lisans